PCV21 (21-valent pneumococcal conjugate vaccine)

pneumococcal conjugate vaccine, 21-valent · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PCV21 (21-valent pneumococcal conjugate vaccine), covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age [Phase 3]

See pricing